Side Effects of Oxycodone in Adolescents
Oxycodone causes common side effects in teens including constipation, nausea, drowsiness, vomiting, dizziness, and headache, with serious risks of respiratory depression, addiction, overdose, and death—particularly when combined with benzodiazepines or alcohol. 1
Common Side Effects
The most frequently reported side effects of oxycodone in adolescents mirror those in adults and include 1, 2:
- Gastrointestinal: Constipation (most common), nausea, vomiting, abdominal pain
- Central nervous system: Drowsiness/sleepiness, dizziness, headache, lightheadedness
- General: Tiredness, sweating
These effects tend to be dose-dependent and may decrease in intensity over time with continued use 3. Compared to morphine, oxycodone appears to cause somewhat less nausea, hallucinations, and pruritus 3.
Life-Threatening Risks
Respiratory Depression
The most serious risk is life-threatening respiratory depression, which can occur even at prescribed doses 1. This risk is dramatically increased when oxycodone is combined with:
- Benzodiazepines
- Alcohol
- Other central nervous system depressants
- In patients with compromised respiratory function
The risk is highest when first starting oxycodone, after dose increases, or with accidental overdose 1.
Addiction and Misuse in Adolescents
Adolescents face particularly high risks of opioid misuse and addiction 4, 5:
- 18% of adolescents prescribed opioids will misuse them 4
- 13.9% of youth who misuse opioids meet criteria for opioid dependence or abuse 4
- Adolescents tend to underestimate opioid risks, with 41% believing prescription drugs are safer than illegal drugs 6
- Pain relief is cited as the primary motive for misuse in 56-84% of adolescent cases 6
Overdose Risk
Opioid overdose deaths among adolescents are at a 30-year high 7. Accidental ingestion of even one dose can be fatal, especially in children 1. The presence of illicit fentanyl in the drug supply has made unintentional overdose even more dangerous 7.
Developmental Concerns
Chronic opioid use during adolescence carries unique risks due to ongoing brain development 6:
- Substance use can have long-lasting adverse effects on the developing brain
- Any opioid exposure during adolescence carries potential long-term risks for later non-medical prescription opioid use in early adulthood 6
- Concerns exist about the impact of chronic opioid agonism on brain and endocrine system development 7
Withdrawal Symptoms
If oxycodone is used regularly and then stopped abruptly, withdrawal symptoms can occur 8:
- Behavioral: Anxiety, agitation, insomnia, tremors
- Physiologic: Increased muscle tone, nausea, vomiting, diarrhea, decreased appetite, rapid breathing, rapid heart rate, fever, sweating, high blood pressure
Drug Interactions
Oxycodone is metabolized by CYP3A4, creating significant interaction risks 7:
- CYP3A4 inhibitors (including SSRIs commonly used for psychiatric conditions) can increase oxycodone levels, potentially causing overdose
- This is particularly relevant since adolescents with substance use often have co-occurring psychiatric disorders requiring psychotropic medications
Cardiovascular and Other Effects
Additional serious but less common effects include 7:
- QTc prolongation and cardiac arrhythmias
- Orthostatic hypotension
- Central sleep apnea
- Adrenal insufficiency
- Hormonal effects (lowered testosterone, amenorrhea)
Critical Clinical Pitfalls
Avoid these common errors:
Never prescribe codeine or tramadol to children under 12 years (FDA black-box warning) or adolescents with obesity/OSA—use oxycodone or other alternatives instead 9, 4
Do not assume adolescents understand opioid risks—explicit education about addiction potential, overdose risk, and proper storage/disposal is essential 1, 5
Screen for diversion risk—26% of adolescents who misuse opioids use their own prescription, and 39% obtain them from friends/relatives 4
Co-prescribe naloxone for all adolescents receiving opioids, especially those with prior overdose history 7, 5
Monitor for benzodiazepine co-use—this combination dramatically increases respiratory depression and death risk 1